U.S. and Europe Bioreactor Bags Market Size, Share, and Trends 2026 to 2035

Payal Rabde, a Healthcare Industry Expert, highlights that the U.S. & Europe bioreactor bags market has reached USD 1.68 billion in 2026 and is on track to reach USD 5.20 billion by 2035, advancing at a CAGR of 13.4%. Key U.S. & Europe bioreactor bags market companies shaping the market include Sartorius, Thermo Fisher Scientific, Cytiva (Danaher), while major growth segments span type, Volume, application, end-user.

Last Updated : 20 Nov 2026  |  Report Code : 8994  |  Category : Healthcare   |  Format : PDF / PPT / Excel

1. Market Overview & Sizing

1.1 U.S. & Europe Bioreactor Bags Market: Definition and Scope

1.1.1 Market Definition and Scope of Study

1.1.2 Inclusions and Exclusions

1.1.3 Currency, Units and Base Year

1.2 U.S. & Europe Bioreactor Bags Market Taxonomy

1.2.1 By Type

1.2.2 By Volume

1.2.3 By Application

1.2.4 By End User

1.3 U.S. & Europe Bioreactor Bags Market Size and Forecast, 2025-2035

1.3.1 Market Value (USD) and Annual Growth

1.3.2 Historical Market Analysis

1.3.3 Market Growth Analysis and CAGR 2026-2035

1.4 U.S. & Europe Bioreactor Bags Market Penetration and Maturity Analysis

1.5 Addressable Market Analysis (TAM, SAM, SOM) for U.S. & Europe Bioreactor Bags

1.6 U.S. & Europe Bioreactor Bags Market Value Chain Analysis

1.7 U.S. & Europe Bioreactor Bags Market Ecosystem Analysis

2. Market Dynamics & Opportunities

2.1 U.S. & Europe Bioreactor Bags Market Dynamics Overview

2.2 Growth Drivers

2.2.1 Biologics growth

2.2.2 Cell and gene therapy

2.2.3 CDMO expansion

2.2.4 Faster facility build

2.3 Market Drivers - Impact & CAGR Contribution (2026-2035)

2.4 Market Restraints

2.4.1 Plastic waste

2.4.2 Supply concentration

2.4.3 Extractables concerns

2.4.4 Bag failures

2.5 Market Restraints - Impact & Negative CAGR Contribution (2026-2035)

2.6 Market Challenges

2.7 Emerging Opportunities

2.7.1 Cell therapy

2.7.2 Large-scale bags

2.7.3 Recyclable films

2.7.4 Perfusion

2.8 Key Trends in the U.S. & Europe Bioreactor Bags Market

2.8.1 Larger single-use bags

2.8.2 Cell therapy bags

2.8.3 Film supply security

2.8.4 Bag integrity testing

2.8.5 Recyclable films

2.8.6 Perfusion processes

2.9 Unmet Needs, White Space and Gap Analysis

2.10 Industry Evolution and Transformation of the U.S. & Europe Bioreactor Bags Market

3. Segmentation & Forecast

3.1 U.S. & Europe Bioreactor Bags Market, by Type (Share %, 2025-2035)

3.1.1 3D Stirred-Tank Bags: Market Share and CAGR

3.1.2 2D Rocking Bags: Market Share and CAGR

3.2 U.S. & Europe Bioreactor Bags Market, by Volume (Share %, 2025-2035)

3.2.1 Up to 50 L: Market Share and CAGR

3.2.2 50-500 L: Market Share and CAGR

3.2.3 500-2,000 L & Above: Market Share and CAGR

3.3 U.S. & Europe Bioreactor Bags Market, by Application (Share %, 2025-2035)

3.3.1 Monoclonal Antibodies: Market Share and CAGR

3.3.2 Vaccines: Market Share and CAGR

3.3.3 Cell & Gene Therapies: Market Share and CAGR

3.3.4 Others: Market Share and CAGR

3.4 U.S. & Europe Bioreactor Bags Market, by End User (Share %, 2025-2035)

3.4.1 Biopharmaceutical Companies: Market Share and CAGR

3.4.2 CDMOs: Market Share and CAGR

3.4.3 Academic & Research Institutes: Market Share and CAGR

3.5 Segment Attractiveness and Growth Comparison

4. Regional & Country Intelligence

4.1 U.S. & Europe Bioreactor Bags Market: U.S.

4.1.1 Market Size and Forecast, 2025-2035

4.1.2 Market Share by Type

4.1.3 Demand Drivers, Regulation and Local Competition

4.2 U.S. & Europe Bioreactor Bags Market: Europe

4.2.1 Market Size and Forecast, 2025-2035

4.2.2 Market Share by Type

4.2.3 Demand Drivers, Regulation and Local Competition

4.3 Region Attractiveness and Market Entry Assessment

5. Competitive & Company Intelligence

5.1 U.S. & Europe Bioreactor Bags Market Competitive Landscape Overview

5.2 Market Share by Company, 2025

5.3 Company Ranking and Competitive Indexing

5.4 Precedence Research Companies Quadrant

5.5 Competitive Benchmarking

5.5.1 Product Portfolio Benchmarking

5.5.2 Geographic Presence Benchmarking

5.5.3 Technology and Innovation Benchmarking

5.6 Strategic Group Mapping

5.7 Barriers to Entry and New Entrant Analysis

5.8 Mergers, Acquisitions and Strategic Partnerships

5.9 Recent Developments in the U.S. & Europe Bioreactor Bags Market

6. Pricing Intelligence

6.1 U.S. & Europe Bioreactor Bags Market Pricing Overview

6.1.1 Instrument list price and discount analysis

6.1.2 Consumables and reagent pricing per test or sample

6.1.3 Service contract and subscription pricing

6.1.4 Academic vs. biopharma pricing tiers

6.2 Pricing by Type

6.3 Pricing by Region

6.4 Historical Price Trend and Price Forecast, 2025-2035

6.5 Cost Structure, Margin and Price Sensitivity Analysis

6.6 Competitor Pricing Benchmarking

7. Buyer & Customer Intelligence

7.1 U.S. & Europe Bioreactor Bags Market Buyer Landscape

7.1.1 Pharmaceutical and biotechnology companies

7.1.2 Academic and government research institutes

7.1.3 CROs, CDMOs and core facilities

7.1.4 Clinical and diagnostic laboratories

7.2 Buyer Segmentation and Purchasing Patterns

7.3 Buying Criteria and Decision-Making Process

7.4 Customer Pain Points and Unmet Needs

7.5 Customer Retention, Switching and Loyalty Analysis

8. Buying, Selling & Procurement

8.1 Procurement Strategies and Supplier Selection Criteria

8.2 Sales Channel Analysis: Direct vs. Indirect

8.3 Distributor and Dealer Network Analysis

8.4 Key Account and Contract Analysis

8.5 Cross-Selling and Upselling Opportunities

9. Supply Chain & Manufacturing

9.1 U.S. & Europe Bioreactor Bags Market Supply Chain Mapping

9.1.1 Key raw materials and component sourcing

9.1.2 OEM and contract manufacturing

9.1.3 Distributor and e-procurement channels

9.1.4 Cold chain and logistics requirements

9.2 Supplier Landscape and Concentration

9.3 Manufacturing Footprint and Capacity Analysis

9.4 Supply Chain Risk and Resilience

10. Trade & Distribution

10.1 Import and Export Analysis

10.2 Major Exporting and Importing Countries

10.3 Tariffs, Duties and Trade Regulations

10.4 Distribution Channel Share and E-commerce Analysis

11. Technology & Innovation

11.1 U.S. & Europe Bioreactor Bags Market Technology Landscape

11.1.1 Automation and high-throughput workflows

11.1.2 Digital, cloud and AI-enabled analysis

11.1.3 Next-generation platforms and consumables

11.1.4 Patent and IP landscape

11.2 Innovation Pipeline and R&D Investment Analysis

11.3 Technology Adoption and Readiness Analysis

11.4 Future Technology Roadmap

12. Regulatory & Risk

12.1 U.S. & Europe Bioreactor Bags Market Regulatory Landscape

12.1.1 Research-use-only vs. IVD regulatory pathways

12.1.2 GMP and quality standards for bioprocessing

12.1.3 Biosafety and laboratory standards

12.1.4 Data integrity and compliance requirements

12.2 Regulatory Risk and Compliance Cost Analysis

12.3 Political, Economic and Supply Risk Assessment

13. Investment & Financial

13.1 U.S. & Europe Bioreactor Bags Market Investment Landscape

13.2 Funding, Venture Capital and Private Equity Activity

13.3 M&A Landscape and Valuation Benchmarking

13.4 Revenue Pool and Profit Pool Analysis

13.5 Investment Opportunity Mapping

14. GTM & Commercial Strategy

14.1 Market Entry and Expansion Strategy

14.2 Go-to-Market Strategy by Customer Segment

14.3 Partnership and Commercialisation Opportunities

14.4 Opportunity Prioritisation Matrix

15. Advanced Forecasting & Scenarios

15.1 Scenario-Based Forecast for the U.S. & Europe Bioreactor Bags Market (Base, Optimistic, Pessimistic)

15.2 Sensitivity Analysis of Key Assumptions

15.3 Demand-Supply Gap Forecast

15.4 Market Risk and Uncertainty Assessment

15.5 Long-Term Market Outlook to 2035

16. Industry-Specific Intelligence: Life Science Tools

16.1 Research funding and grant analysis

16.2 Biopharma R&D pipeline linkage

16.3 Installed base and consumables pull-through

16.4 Laboratory adoption and workflow analysis

16.5 Clinical translation and IVD potential

16.6 Outsourcing trends in research and manufacturing

17. Company Profiles & Benchmarking

17.1 Sartorius

17.1.1 Company Overview

17.1.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.1.3 Financial Performance and Market Share

17.1.4 Recent Developments and Strategy

17.1.5 SWOT Analysis

17.2 Thermo Fisher Scientific

17.2.1 Company Overview

17.2.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.2.3 Financial Performance and Market Share

17.2.4 Recent Developments and Strategy

17.2.5 SWOT Analysis

17.3 Cytiva (Danaher)

17.3.1 Company Overview

17.3.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.3.3 Financial Performance and Market Share

17.3.4 Recent Developments and Strategy

17.3.5 SWOT Analysis

17.4 Merck KGaA (MilliporeSigma)

17.4.1 Company Overview

17.4.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.4.3 Financial Performance and Market Share

17.4.4 Recent Developments and Strategy

17.4.5 SWOT Analysis

17.5 Getinge (Applikon)

17.5.1 Company Overview

17.5.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.5.3 Financial Performance and Market Share

17.5.4 Recent Developments and Strategy

17.5.5 SWOT Analysis

17.6 Eppendorf

17.6.1 Company Overview

17.6.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.6.3 Financial Performance and Market Share

17.6.4 Recent Developments and Strategy

17.6.5 SWOT Analysis

17.7 Saint-Gobain Life Sciences

17.7.1 Company Overview

17.7.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.7.3 Financial Performance and Market Share

17.7.4 Recent Developments and Strategy

17.7.5 SWOT Analysis

17.8 Corning

17.8.1 Company Overview

17.8.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.8.3 Financial Performance and Market Share

17.8.4 Recent Developments and Strategy

17.8.5 SWOT Analysis

17.9 PBS Biotech

17.9.1 Company Overview

17.9.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.9.3 Financial Performance and Market Share

17.9.4 Recent Developments and Strategy

17.9.5 SWOT Analysis

17.10 Entegris

17.10.1 Company Overview

17.10.2 U.S. & Europe Bioreactor Bags Product Portfolio

17.10.3 Financial Performance and Market Share

17.10.4 Recent Developments and Strategy

17.10.5 SWOT Analysis

18. Strategic Recommendations

18.1 Recommendations for Manufacturers and Suppliers in the U.S. & Europe Bioreactor Bags Market

18.2 Recommendations for Investors

18.3 Recommendations for Buyers and End Users

18.4 Key Success Factors

19. Analyst View & FAQs

19.1 Analyst View on the U.S. & Europe Bioreactor Bags Market

19.2 Research Methodology and Data Validation

19.3 Frequently Asked Questions

19.4 Sources and Abbreviations

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The U.S. & Europe bioreactor bags market was valued at USD 1.48 billion in 2025 and is estimated at USD 1.68 billion in 2026. It is projected to reach USD 5.20 billion by 2035.

Answer : The U.S. & Europe bioreactor bags market is expected to grow at a CAGR of 13.4% from 2026 to 2035, driven by biologics growth, cell and gene therapy, CDMO expansion and faster facility build.

Answer : 3D stirred-tank bags lead the U.S. & Europe bioreactor bags market with a 68% share in 2025, because they are used in production-scale single-use bioreactors.

Answer : The U.S. dominates the U.S. & Europe bioreactor bags market with a 58% share in 2025 and is also the fastest-growing region.

Answer : Key players in the U.S. & Europe bioreactor bags market include Sartorius, Thermo Fisher Scientific, Cytiva (Danaher), Merck KGaA (MilliporeSigma), Getinge (Applikon), Eppendorf, Saint-Gobain Life Sciences, Corning, PBS Biotech, and other players.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client